|Bid||0.00 x 800|
|Ask||0.00 x 900|
|Day's Range||10.53 - 11.16|
|52 Week Range||5.72 - 19.34|
|Beta (5Y Monthly)||1.53|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Representing IVERIC bio today are Mr. Glenn Sblendorio, chief executive officer; Dr. Pravin Dugel, president; Keith Westby, chief operating officer; Dave Carroll, chief financial officer; Dr. In addition, any forward-looking statements represent our views only as of today and should not be relied upon as representing our views as of any subsequent date.
We can readily understand why investors are attracted to unprofitable companies. Indeed, IVERIC bio ( NASDAQ:ISEE...
Representing IVERIC bio today are Mr. Glenn Sblendorio, chief executive officer; Dr. Pravin Dugel, president; Mr. And we are pleased to welcome Mr. Tony Gibney as chief business and strategy officer.